Skip to main content
. 2020 May 31;23:100300. doi: 10.1016/j.jbo.2020.100300

Table 5.

The immunohistochemistry results of Sox-9 protein evaluation in patients with bone cancer.

Scores Osteosarcoma Ewing's Sarcoma Chondrosarcoma Chemotherapy received patients
Negative 12% 24% 24% 23%
Positive (1+) 16% 20% 40% 16%
Positive (2+) 32% 28% 20% 40%
Positive (3+) 40% 28% 16% 21%
Scores Osteochondroma Giant cell Tumor Exostosis Metastatic patients

Negative 48% 60% 56% 0
Positive (1+) 16% 20% 20% 4.16%
Positive (2+) 36% 20% 24% 25%
Positive (3+) 0 0 0 70.83%